SCT

Singlecell Technology Market Landscape 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 18, 2022

The "Singlecell Technology Market Landscape 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Singlecell Technology Market Landscape 2022" report has been added to ResearchAndMarkets.com's offering.
  • The global single-cell technology (SCT) market has emerged since the mid-2010s.
  • There are 58+ SCT commercial products from 52 companies and over 30 pre-commerce-stage startups to enter the market in the next few years (another report).
  • The market share is highly concentrated on the four major companies 10x genomics, Fluidigm, BD biosciences, and Berkeley light, yet this market share can change as the market expands with more players.

nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting

Retrieved on: 
Wednesday, June 22, 2022

CRAB is dedicated to providing statistics and data management operations and leadership support for the SWOG SDMC.

Key Points: 
  • CRAB is dedicated to providing statistics and data management operations and leadership support for the SWOG SDMC.
  • The poster session summarized the results to date of the SWOG-nCartes Pilot Collaboration.
  • In late-phase pilot testing, the results of data entry using the nCartes platform were compared to the current practice of manual data entry.
  • To measure data entry time, an experienced study coordinator was timed entering 43 forms using nCartes.

CalAmp Partners with assured Techmatics to Deliver Data Insights for Commercial Fleet ELD Compliance in United States, Canada and Mexico

Retrieved on: 
Tuesday, June 21, 2022

Together with CalAmps edge computing devices, the company will offer assured Techmatics apollo Electronic Logging Device (ELD) solution to commercial and public fleet operators, enabling them to capture and log critical data necessary for regulatory compliance.

Key Points: 
  • Together with CalAmps edge computing devices, the company will offer assured Techmatics apollo Electronic Logging Device (ELD) solution to commercial and public fleet operators, enabling them to capture and log critical data necessary for regulatory compliance.
  • ELD data will be integrated with other tractor, trailer and cargo insights and accessible through CalAmps portfolio of Software-as-a-Service (SaaS) or Platform-as-a-Service (PaaS) solutions.
  • The data that the assured Techmatics apollo ELD system collects for compliance purposes perfectly complements our full stack of fleet and asset tracking solutions.
  • Stolen Vehicle Recovery (SVR) business from CalAmp and holds an exclusive license to the LoJack mark in the United States and Canada.

SoCal Token strives to change the narratives of the crypto space with its exclusive features.

Retrieved on: 
Friday, June 10, 2022

Los Angeles, CA, June 10, 2022 (GLOBE NEWSWIRE) -- SoCal Token strives to change the narratives of the crypto space with its exclusive features.

Key Points: 
  • Los Angeles, CA, June 10, 2022 (GLOBE NEWSWIRE) -- SoCal Token strives to change the narratives of the crypto space with its exclusive features.
  • SoCal Token strives to be passionate stewards of the crypto space.
  • Ultimately, the mission is to cultivate a fun, transparent, and prosperous platform inspiring both current and future generations of investors.
  • All holders of $SCT will gain access to online informative crypto education classes held once a week, covering all aspects of the crypto world.

CEO compensation jumped 15.7% in 2021, WTW proxy analysis finds

Retrieved on: 
Thursday, June 9, 2022

The WTW analysis found total pay for CEOs jumped 15.7% in 2021, sharply higher than the 3.2% median increase in 2020.

Key Points: 
  • The WTW analysis found total pay for CEOs jumped 15.7% in 2021, sharply higher than the 3.2% median increase in 2020.
  • The value of target long-term incentives jumped 9.1% in 2021, compared with a 5.5% increase at the median in 2020.
  • Last year was a bounce-back year for CEO compensation as well as a good year financially for many companies and shareholders, said Don Delves, North America practice leader of Executive Compensation at WTW.
  • At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital.

Krypt Partners With SCT Software to Provide Customers With an Extended Adaptable Supply Chain Experience Within SAP

Retrieved on: 
Thursday, May 26, 2022

SAN JOSE, Calif. , May 26, 2022  /PRNewswire-PRWeb/ -- "Teaming up with SCT Software will allow us to provide our customers with a complete, end-to-end supply chain solution. The specialized expertise provided by SCT is a perfect complement to Krypt's SAP Supply Chain and Global Trade solutions expertise. Our aim is to provide our customers with the most seamless supply chain experience possible, while providing the highest quality services and support. We are thrilled to take this concept to the next level with the SCT partnership," said Brian Thorn, Chief Revenue Officer, for Krypt.

Key Points: 
  • Krypt and SCT Software announced a strategic partnership that addresses customer requirements for an extended, adaptable, supply chain experience utilizing SAP solutions.
  • The specialized expertise provided by SCT is a perfect complement to Krypt's SAP Supply Chain and Global Trade solutions expertise.
  • The Krypt Adaptable Supply Chain (KASC) is an integrated and streamlined digital supply chain combining best-in-class SAP software solutions, the expertise of Krypt's team and IP to provide customers with a seamless supply chain experience.
  • This is accomplished by delivering solutions that work seamlessly with SAP Supply Chain offerings including SAP EWM, SAP TM, SAP BNL and SAP GTT.

Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform

Retrieved on: 
Wednesday, May 11, 2022

ROCKVILLE, Md., May 11, 2022 /PRNewswire/ -- Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th. The cloud platform of Advantage eClinical will be available as a standalone software product after undergoing more than two years of development. The system has been specifically designed to provide fast study builds, greater flexibility, and insights to clinical trial sponsors of all sizes.

Key Points: 
  • The cloud platform of Advantage eClinical will be available as a standalonesoftwareproduct after undergoing more than two years of development.
  • Advantage eClinical provides a fully integrated suite of data management applications backed by decades of domainexpertise.
  • This is exactly what we have set out to address with our third-generation Advantage eClinical platform,"commented Hemang Maniar, Chief Information Officer at Emmes.
  • Advantage eClinical has supported over 1,000 trials, for nearly one million patients in over 70countries, spanning more than 31,000 clinical trial sites.

MyComplianceOffice Announces Close of Schwab Compliance Technologies Acquisition

Retrieved on: 
Monday, May 2, 2022

MCO ( MyComplianceOffice ), a global provider of conduct risk and compliance technology, today announced that the company has finalized its acquisition of Schwab Compliance Technologies (SCT), a solution that automates monitoring employee trading activity and administering a firm's Code of Ethics.

Key Points: 
  • MCO ( MyComplianceOffice ), a global provider of conduct risk and compliance technology, today announced that the company has finalized its acquisition of Schwab Compliance Technologies (SCT), a solution that automates monitoring employee trading activity and administering a firm's Code of Ethics.
  • Additionally, as part of the sale, the Schwab Compliance Technologies (SCT) product name was changed to MyComplianceTechnologies (MCT).
  • Their knowledge and passion will help to bring together the best of both products, quickly and effectively, and ensure best-in-class KYE compliance for all.
  • Our history of product innovation and strong client focus will help to cement the success of this acquisition and drive product growth for years to come.

Pack Health & UCSF Publish Usability Study of Digital Coaching for Patients Undergoing SCT in JMIR

Retrieved on: 
Wednesday, April 13, 2022

BIRMINGHAM, Ala., April 13, 2022 /PRNewswire/ -- Leading patient engagement platform Pack Health today announced the publication of their recent study, "Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study" in the Journal of Medical Internet Research (JMIR) Formative Research. Pack Health collaborated with the University of California at San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center on this research. The study detailed in the publication examined digital life coaching (DLC) as a viable intervention for patients with multiple myeloma before and after their autologous stem cell transplantation (SCT) procedures, as well as how it would affect their overall quality of life.

Key Points: 
  • BIRMINGHAM, Ala., April 13, 2022 /PRNewswire/ -- Leading patient engagement platform Pack Health today announced the publication of their recent study, "Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study" in theJournal of Medical Internet Research (JMIR) Formative Research.
  • Pack Health collaborated with the University of California at San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center on this research.
  • To evaluate the feasibility of DLC for this study, patients received 16 weeks of access to personalized digital coaching with a Health Advisor from Pack Health.
  • Pack Health comprehensively addresses chronic conditions, comorbidities, social determinants, and barriers to drive results across industries, including life sciences, health systems, health plans, and research.

Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting

Retrieved on: 
Sunday, April 10, 2022

Still the combination of AFM13 and precomplexed NK cells resulted in a 100% response rate and a 62% rate of complete responses.

Key Points: 
  • Still the combination of AFM13 and precomplexed NK cells resulted in a 100% response rate and a 62% rate of complete responses.
  • There were six infusion-related reactions in 110 infusions (5.4%) of AFM13 alone and no reactions to the cord blood-derived NK cells precomplexed with AFM13.
  • When precomplexed with AFM13, NK cells exhibit immediate expansion in the patients circulation which persists for at least two weeks.
  • The study is a dose-escalation trial of pre-complexed NK cells, with patients receiving 1106 NK cells/kg in Cohort 1; 1107 NK cells/kg in Cohort 2; and 1108 NK cells/kg in Cohort 3.